ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Novelix Pharmaceuticals Limited will hold its 32nd Annual General Meeting on September 30, 2026. The company has fixed September 23, 2026, as the cut-off date for e-voting.
Novelix Pharmaceuticals held an Extra Ordinary General Meeting on July 1, 2026. The meeting included a special resolution for issuing equity shares on preferential basis.
Novelix Pharmaceuticals convened an EGM for July 1, 2026, to approve a ₹6.84 Crore preferential allotment. The capital raise targets non-promoter investors to fund technology transfers.
Novelix Pharmaceuticals has scheduled an EGM for July 01, 2026, via video conferencing. The board fixed June 24, 2026, as the cut-off date for shareholder e-voting eligibility.